Aichong Biotech
Company Profile
Focus on pets and jointly build the health of humans and pets

Pet Biotech adheres to the principle of human drug level research and production standards, focusing on deepening the field of pet vaccines, drugs, and nutritional health products. Its subsidiary, Pet Pai Pure ®、 Super naughty ®、 Pet Protection Yi's Home ® By partnering with multiple brands and implementing a refined layout, we are committed to improving sub-health and preventing pet diseases, helping to reduce the harm of zoonotic diseases, enhance the safety of living environments for humans and pets, and jointly build a healthy environment for both humans and pets.
The company integrates product research and development, production, and sales, with two self owned production bases in Guangxi and Anhui, as well as the R&D center of Shanghai Pet Research Institute. The company is committed to building a comprehensive pipeline of pet medicine and health products with innovative R&D technology and advanced equipment, focusing on developing technology-based health solutions with technological advantages.
Company history
The "triple inactivated vaccine for feline panleukopenia, infectious rhinoconjunctivitis, and infectious rhinotracheitis (VP2 protein+C3 strain+CP2 strain)" and "double inactivated vaccine for canine distemper and parvovirus disease" declared by Pet Biolo
2023
2022
The Guangxi factory of Aichong Biotech was approved the "GMP Certificate of Veterinary Drugs" and the "Veterinary Drug Production License", and the Hefei base of Aichong Biotech was successfully started to build a domestic high-end vaccine pet
Aichong Biotech established a "Pet Health Research Center" in Shanghai Zhangjiang Pharmaceutical Valley, and Aichong Biotech built a pet vaccine chemical industry base in Anhui Hefei Heru Industrial Park.
2021
2020
Aichong Biotech accelerates the overall layout and expansion of the companion animal product matrix.
Company philosophy
Mission
Adhering to the original intention of "taking the R&D and production quality of human medicine as the standard", keeping a close eye on the forefront of the industry, bravely taking the lead, continuing to research, innovate and make breakthroughs, practicing the line of combining the professionalism of pet health management research with the innovation of the pet industry, and providing high-quality products and dedication to hundreds of millions of pets.
Vision
become the largest partner animal pharmaceutical product industry group in China.
Value
Jointly build the pet life ecosystem and lay out the intelligent health management product line.
Social Responsibility
Aichong biological set up pet health research center human drug quality of pet medicine.
Aichong biological pet Health Research Center was officially announced in Shanghai Zhangjiang Medicine Valley, and the expert committee of pet Health Research Center was simultaneously unveiled.
Aichong Biology won the most influential industry brand in 2021.
The 7th Golden Gull Awards Ceremony and the 6th CEO New Year Summit were successfully held, with the theme of "Innovation forces rise against the trend".
To create China's "Zoetis" : Aichong biological deer pet medical head brand.
Guangxi Factory of Aichong Group and Hezhou University have in-depth school-enterprise cooperation.
回到顶部